2020
DOI: 10.1016/j.carrev.2019.11.011
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database for Patient- and Circuit-Related Adverse Events Involving Extracorporeal Membrane Oxygenation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 17 publications
0
4
0
Order By: Relevance
“…As one of the core components of ECMO, a blood pump has a considerable impact on the therapeutic effect and development of ECMO. 3,4 Centrifugal pump delivers fluid through the centrifugal force generated by the high-speed rotation of the impeller with the ability to generate high flow at low pressure; patients can be conveniently transferred during extracorporeal life support (ECLS) owing to the small size of this pump. 5,6 Therefore, centrifugal pumps are conventionally used in recent years in clinics because of their simplicity and portability.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…As one of the core components of ECMO, a blood pump has a considerable impact on the therapeutic effect and development of ECMO. 3,4 Centrifugal pump delivers fluid through the centrifugal force generated by the high-speed rotation of the impeller with the ability to generate high flow at low pressure; patients can be conveniently transferred during extracorporeal life support (ECLS) owing to the small size of this pump. 5,6 Therefore, centrifugal pumps are conventionally used in recent years in clinics because of their simplicity and portability.…”
Section: Introductionmentioning
confidence: 99%
“…ECMO supports cardiac output and oxygenation through a blood pump to achieve circulating flow. As one of the core components of ECMO, a blood pump has a considerable impact on the therapeutic effect and development of ECMO 3,4 …”
Section: Introductionmentioning
confidence: 99%
“…Review of the FDA MAUDE database has also demonstrated the high rate of complications associated with ECMO (14). Reporting to the MAUDE database is mandatory for manufacturers, importers, and device user facilities but is voluntary for consumers, patients, and health care professionals.…”
mentioning
confidence: 99%
“…However, nosocomial infection remains one of the major complications associated with ECMO support. 2 Most patients who require ECMO often have infections initially and are more likely to develop nosocomial infections via indwelling cannulas, altered host immune function, urinary catheters, and endotracheal tubes. Microbial colonization of ECMO devices such as ECMO cannulas and oxygenators may cause bloodstream infections (BSIs).…”
mentioning
confidence: 99%